| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EIGR | Eiger BioPharmaceuticals, Inc. | KAYNE RICHARD A | 10% Owner | Nov 01, 2023 | Buy | $0.28 | 100,000 | 27,970 | 5,351,827 | Nov 02, 2023, 09:21 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | KAYNE RICHARD A | 10% Owner | Nov 02, 2023 | Buy | $0.30 | 23,398 | 6,966 | 5,375,225 | Nov 02, 2023, 09:21 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | KAYNE RICHARD A | 10% Owner | Oct 31, 2023 | Buy | $0.24 | 154,841 | 37,880 | 5,251,827 | Nov 02, 2023, 09:21 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | KAWAS LEEN | 10% Owner | Oct 31, 2023 | Buy | $0.26 | 24,332 | 6,375 | 4,391,432 | Nov 02, 2023, 09:14 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mayer Eldon C. III | Ex VP & Chief Commerc. Officer | Mar 17, 2023 | Sale | $1.07 | 4,395 | 4,704 | 57,948 | Mar 21, 2023, 09:00 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Dietz Thomas John | Director | Jan 23, 2023 | Buy | $1.43 | 50,000 | 71,580 | 50,000 | Jan 25, 2023, 08:54 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Murray Christine | Director | Dec 29, 2022 | Sale | $1.22 | 5,000 | 6,104 | 11,000 | Jan 03, 2023, 08:30 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Dietz Thomas John | Director | Dec 22, 2022 | Sale | $1.17 | 22,500 | 26,303 | 21,000 | Dec 27, 2022, 05:31 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Glenn Jeffrey S | Director | Dec 22, 2022 | Buy | $1.28 | 100,000 | 127,950 | 182,355 | Dec 27, 2022, 05:31 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Apelian David | Director | Aug 16, 2022 | Sale | $9.81 | 5,000 | 49,030 | 11,000 | Aug 18, 2022, 05:36 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Ryali Sriram | Chief Financial Officer | Mar 14, 2022 | Sale | $5.60 | 2,266 | 12,683 | 41,566 | Mar 14, 2022, 09:22 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mayer Eldon C. III | Ex VP & Chief Commerc. Officer | Mar 14, 2022 | Sale | $5.60 | 1,657 | 9,275 | 60,468 | Mar 14, 2022, 09:21 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mayer Eldon C. III | Ex VP & Chief Commerc. Officer | Jan 07, 2022 | Sale | $4.95 | 1,560 | 7,722 | 46,125 | Jan 11, 2022, 08:59 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Dietz Thomas John | Director | Apr 09, 2021 | Buy | $8.49 | 2,500 | 21,220 | 37,500 | Apr 12, 2021, 06:10 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Loh Evan | Director | Mar 15, 2021 | Sale | $10.14 | 2,000 | 20,280 | 8,000 | Mar 15, 2021, 07:30 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mayer Eldon C. III | Ex VP & Chief Commerc. Officer | Jan 08, 2021 | Sale | $11.68 | 1,690 | 19,739 | 35,810 | Jan 11, 2021, 06:10 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Glenn Jeffrey S | Director | Aug 11, 2020 | Buy | $11.49 | 5,000 | 57,463 | 71,355 | Aug 12, 2020, 06:28 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Glenn Jeffrey S | Director | Aug 12, 2020 | Buy | $11.42 | 5,000 | 57,103 | 5,000 | Aug 12, 2020, 06:28 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Dietz Thomas John | Director | Mar 16, 2020 | Buy | $4.95 | 1,000 | 4,950 | 30,000 | Mar 17, 2020, 05:17 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Glenn Jeffrey S | Director | Mar 16, 2020 | Buy | $5.03 | 30,000 | 150,813 | 66,355 | Mar 17, 2020, 05:16 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | Mar 05, 2020 | Option Exercise | $7.31 | 1,500 | 10,965 | 15,921 | Mar 13, 2020, 05:40 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Ryali Sriram | Chief Financial Officer | Mar 05, 2020 | Option Exercise | $7.31 | 229 | 1,674 | 1,628 | Mar 13, 2020, 05:35 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Patton Stephana Eilene | See Remarks | Mar 05, 2020 | Option Exercise | $7.31 | 820 | 5,994 | 4,820 | Mar 13, 2020, 05:30 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Cory David A | President and CEO | Mar 05, 2020 | Option Exercise | $7.31 | 1,500 | 10,965 | 69,346 | Mar 13, 2020, 05:23 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mayer Eldon C. III | Ex VP & Chief Commerc. Officer | Jan 24, 2020 | Buy | $13.52 | 5,000 | 67,603 | 30,000 | Jan 30, 2020, 04:44 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Dietz Thomas John | Director | Jan 10, 2020 | Buy | $13.94 | 4,000 | 55,760 | 24,000 | Jan 13, 2020, 08:17 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | Sep 05, 2019 | Option Exercise | $7.95 | 1,500 | 11,921 | 14,421 | Sep 06, 2019, 06:37 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Ryali Sriram | Chief Financial Officer | Sep 05, 2019 | Option Exercise | $9.37 | 149 | 1,396 | 1,399 | Sep 06, 2019, 05:47 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Cory David A | President and CEO | Sep 05, 2019 | Option Exercise | $7.95 | 1,500 | 11,921 | 67,846 | Sep 06, 2019, 05:46 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Cory David A | President and CEO | Feb 04, 2019 | Buy | $11.26 | 343 | 3,862 | 66,346 | Apr 26, 2019, 04:54 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Dietz Thomas John | Director | Apr 23, 2019 | Buy | $11.10 | 5,000 | 55,495 | 20,000 | Apr 23, 2019, 06:53 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Ryali Sriram | Chief Financial Officer | Apr 22, 2019 | Buy | $11.08 | 1,250 | 13,853 | 1,250 | Apr 22, 2019, 09:34 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Dietz Thomas John | Director | Apr 22, 2019 | Buy | $11.05 | 5,000 | 55,250 | 15,000 | Apr 22, 2019, 09:34 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Patton Stephana Eilene | See Remarks | Apr 22, 2019 | Buy | $11.03 | 1,000 | 11,030 | 4,000 | Apr 22, 2019, 09:31 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | Mar 06, 2017 | Option Exercise | $8.20 | 1,301 | 10,671 | 6,921 | Mar 26, 2019, 10:12 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | Sep 05, 2017 | Option Exercise | $9.90 | 1,500 | 14,854 | 8,421 | Mar 26, 2019, 10:12 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | Mar 05, 2018 | Option Exercise | $8.03 | 1,500 | 12,049 | 9,921 | Mar 26, 2019, 10:12 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | Sep 05, 2018 | Option Exercise | $7.95 | 1,500 | 11,921 | 11,421 | Mar 26, 2019, 10:12 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | Mar 05, 2019 | Option Exercise | $7.95 | 1,500 | 11,921 | 12,921 | Mar 26, 2019, 10:12 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Cory David A | President and CEO | Mar 05, 2019 | Option Exercise | $7.95 | 1,500 | 11,921 | 66,003 | Mar 26, 2019, 10:07 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Cory David A | President and CEO | Mar 06, 2017 | Option Exercise | $8.20 | 1,325 | 10,868 | 60,003 | Mar 26, 2019, 10:07 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Cory David A | President and CEO | Sep 05, 2017 | Option Exercise | $9.90 | 1,500 | 14,854 | 61,503 | Mar 26, 2019, 10:07 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Cory David A | President and CEO | Mar 05, 2018 | Option Exercise | $8.03 | 1,500 | 12,049 | 63,003 | Mar 26, 2019, 10:07 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Cory David A | President and CEO | Sep 05, 2018 | Option Exercise | $7.95 | 1,500 | 11,921 | 64,503 | Mar 26, 2019, 10:07 AM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Cory David A | President and CEO | Feb 04, 2019 | Buy | $14.13 | 227 | 3,208 | 58,678 | Feb 06, 2019, 07:23 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Dietz Thomas John | Director | Dec 20, 2018 | Buy | $9.98 | 5,000 | 49,900 | 10,000 | Dec 20, 2018, 08:29 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Dietz Thomas John | Director | Dec 06, 2018 | Buy | $11.26 | 5,000 | 56,300 | 5,000 | Dec 10, 2018, 04:05 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mayer Eldon C. III | Director | Nov 29, 2018 | Buy | $10.21 | 4,000 | 40,840 | 25,000 | Nov 30, 2018, 02:26 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mayer Eldon C. III | Director | Nov 28, 2001 | Buy | $10.07 | 6,000 | 60,447 | 21,000 | Nov 28, 2018, 08:51 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mayer Eldon C. III | Director | Nov 26, 2018 | Buy | $9.75 | 7,500 | 73,143 | 7,500 | Nov 28, 2018, 08:51 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mayer Eldon C. III | Director | Nov 27, 2018 | Buy | $9.92 | 7,500 | 74,407 | 15,000 | Nov 28, 2018, 08:51 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Desai Keval | 10% Owner | Oct 18, 2018 | Sale | $12.06 | 237,265 | 2,862,321 | 1,388,792 | Oct 22, 2018, 04:33 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Quan Joanne | Chief Medical Officer | Apr 02, 2018 | Option Exercise | $6.03 | 8,000 | 48,240 | 4,000 | Apr 04, 2018, 05:18 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Glenn Jeffrey S | Director | Sep 01, 2017 | Buy | $9.53 | 15,000 | 142,950 | 31,355 | Sep 05, 2017, 06:20 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Glenn Jeffrey S | Director | Nov 17, 2016 | Buy | $12.73 | 15,000 | 190,950 | 16,355 | Nov 21, 2016, 05:11 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Glenn Jeffrey S | Director | Nov 18, 2016 | Buy | $12.90 | 460 | 5,934 | 460 | Nov 21, 2016, 05:11 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | VIVO VENTURES VI AFFIILATES FUND, L.P. | 10% Owner | Aug 18, 2016 | Buy | $16.00 | 186,136 | 2,978,176 | 1,774,096 | Aug 22, 2016, 01:43 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Vivo Ventures Fund VI, L.P. | 10% Owner | Aug 18, 2016 | Buy | $16.00 | 1,364 | 21,824 | 12,996 | Aug 22, 2016, 01:43 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Cory David A | President and CEO | Aug 18, 2016 | Buy | $15.70 | 1,562 | 24,523 | 58,451 | Aug 19, 2016, 07:15 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | Aug 18, 2016 | Buy | $15.70 | 3,125 | 49,062 | 5,620 | Aug 19, 2016, 06:52 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | WELCH JAMES H | Chief Financial Officer | Jun 22, 2016 | Buy | $19.79 | 500 | 9,897 | 2,500 | Jun 22, 2016, 02:55 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | WELCH JAMES H | Chief Financial Officer | Jun 20, 2016 | Buy | $19.80 | 2,000 | 39,592 | 2,000 | Jun 22, 2016, 02:55 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | Jun 13, 2016 | Buy | $22.17 | 1,250 | 27,718 | 2,495 | Jun 14, 2016, 06:45 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | May 19, 2016 | Buy | $19.52 | 500 | 9,760 | 500 | May 23, 2016, 06:37 PM | |
| EIGR | Eiger BioPharmaceuticals, Inc. | Shaffer James P | Chief Business Officer | May 23, 2016 | Buy | $19.99 | 745 | 14,893 | 1,245 | May 23, 2016, 06:37 PM | |
| CLDN | Celladon Corp | ZSEBO KRISZTINA M | Chief Executive Officer | Apr 06, 2015 | Sale | $10.14 | 95,862 | 971,573 | 51,056 | Apr 07, 2015, 04:38 PM | |
| CLDN | Celladon Corp | LABA REBECQUE J | VP, Corporate Operations | Apr 02, 2015 | Sale | $9.52 | 22,024 | 209,749 | 13,907 | Apr 03, 2015, 04:12 PM | |
| CLDN | Celladon Corp | TAKEYA RYAN K | VP, Manufacturing | Apr 01, 2015 | Option Exercise | $10.12 | 8,888 | 89,991 | 5,876 | Apr 03, 2015, 04:09 PM | |
| CLDN | Celladon Corp | ZSEBO KRISZTINA M | Chief Executive Officer | Mar 09, 2015 | Option Exercise | $13.43 | 95,862 | 1,287,795 | 51,056 | Mar 09, 2015, 09:03 PM | |
| CLDN | Celladon Corp | Honig Peter | Director | Mar 06, 2015 | Sale | $17.29 | 10,000 | 172,900 | 5,000 | Mar 09, 2015, 08:58 PM | |
| CLDN | Celladon Corp | Honig Peter | Director | Mar 05, 2015 | Sale | $16.85 | 9,400 | 158,398 | 4,700 | Mar 09, 2015, 08:58 PM | |
| CLDN | Celladon Corp | LABA REBECQUE J | VP, Corporate Operations | Mar 06, 2015 | Sale | $13.07 | 28,000 | 366,020 | 16,895 | Mar 09, 2015, 08:42 PM | |
| CLDN | Celladon Corp | TAKEYA RYAN K | VP, Manufacturing | Mar 02, 2015 | Option Exercise | $9.80 | 15,554 | 152,429 | 9,209 | Mar 03, 2015, 09:13 PM | |
| CLDN | Celladon Corp | LABA REBECQUE J | VP, Corporate Operations | Feb 06, 2015 | Option Exercise | $9.58 | 28,000 | 268,320 | 16,895 | Feb 10, 2015, 06:19 PM | |
| CLDN | Celladon Corp | ZSEBO KRISZTINA M | Chief Executive Officer | Feb 09, 2015 | Sale | $8.97 | 95,862 | 859,593 | 51,056 | Feb 10, 2015, 06:15 PM | |
| CLDN | Celladon Corp | TAKEYA RYAN K | VP, Manufacturing | Feb 02, 2015 | Option Exercise | $8.74 | 15,554 | 135,864 | 9,209 | Feb 03, 2015, 06:21 PM | |
| CLDN | Celladon Corp | RUDY JEFFREY J | VP, Clinical Operations | Jan 09, 2015 | Option Exercise | $9.82 | 20,000 | 196,300 | 11,024 | Jan 12, 2015, 06:28 PM | |
| CLDN | Celladon Corp | ZSEBO KRISZTINA M | Chief Executive Officer | Jan 06, 2015 | Option Exercise | $9.32 | 82,604 | 769,456 | 44,427 | Jan 08, 2015, 06:43 PM | |
| CLDN | Celladon Corp | LABA REBECQUE J | VP, Corporate Operations | Jan 07, 2015 | Sale | $9.21 | 40,000 | 368,400 | 22,895 | Jan 08, 2015, 06:42 PM | |
| CLDN | Celladon Corp | TAKEYA RYAN K | VP, Manufacturing | Jan 02, 2015 | Sale | $10.50 | 15,554 | 163,317 | 9,209 | Jan 05, 2015, 08:44 PM | |
| CLDN | Celladon Corp | ZSEBO KRISZTINA M | Chief Executive Officer | Dec 09, 2014 | Sale | $8.06 | 82,604 | 665,788 | 42,833 | Dec 10, 2014, 07:07 PM | |
| CLDN | Celladon Corp | RUDY JEFFREY J | VP, Clinical Operations | Dec 09, 2014 | Sale | $8.06 | 20,000 | 161,200 | 10,414 | Dec 10, 2014, 06:43 PM | |
| CLDN | Celladon Corp | LABA REBECQUE J | VP, Finance and Administration | Dec 05, 2014 | Sale | $6.95 | 40,000 | 277,800 | 20,691 | Dec 08, 2014, 06:42 PM | |
| CLDN | Celladon Corp | TAKEYA RYAN K | VP, Manufacturing | Dec 01, 2014 | Sale | $6.57 | 15,554 | 102,112 | 8,354 | Dec 02, 2014, 07:01 PM | |
| CLDN | Celladon Corp | RUDY JEFFREY J | VP, Clinical Operations | Nov 14, 2014 | Option Exercise | $6.40 | 36,000 | 230,220 | 18,000 | Nov 18, 2014, 04:05 PM | |
| CLDN | Celladon Corp | Foley Todd | Director | Feb 04, 2014 | Buy | $8.00 | 122,978 | 983,824 | 1,066,775 | Feb 06, 2014, 04:30 PM | |
| CLDN | Celladon Corp | WIKLUND FREDRIK | VP Corp Dvlpmnt & Invs Rltns | Feb 04, 2014 | Buy | $8.00 | 20,000 | 160,000 | 20,000 | Feb 06, 2014, 03:54 PM | |
| CLDN | Celladon Corp | PFIZER INC | 10% Owner | Feb 04, 2014 | Option Exercise | $8.00 | 250,406 | 2,003,248 | 1,794,803 | Feb 06, 2014, 03:53 PM | |
| CLDN | Celladon Corp | Novartis Bioventures Ltd | 10% Owner | Feb 04, 2014 | Buy | $8.00 | 178,923 | 1,431,384 | 1,551,721 | Feb 06, 2014, 03:52 PM | |
| CLDN | Celladon Corp | NARACHI MICHAEL | Director | Feb 04, 2014 | Buy | $8.00 | 62,500 | 500,000 | 62,500 | Feb 06, 2014, 03:50 PM | |
| CLDN | Celladon Corp | Lundbeckfond Invest A/S | 10% Owner | Feb 04, 2014 | Option Exercise | $8.00 | 201,286 | 1,610,288 | 1,745,683 | Feb 06, 2014, 03:47 PM | |
| CLDN | Celladon Corp | Kordel Johan | Director | Feb 04, 2014 | Option Exercise | $8.00 | 201,286 | 1,610,288 | 1,745,683 | Feb 06, 2014, 03:44 PM | |
| CLDN | Celladon Corp | Funder Joshua | Director | Feb 04, 2014 | Option Exercise | $8.00 | 250,406 | 2,003,248 | 1,194,204 | Feb 06, 2014, 03:43 PM | |
| CLDN | Celladon Corp | Enterprise Partners Management LLC | 10% Owner | Feb 04, 2014 | Option Exercise | $8.00 | 146,636 | 1,173,088 | 1,950,184 | Feb 06, 2014, 03:41 PM |
Menu